Antonio R. Pera's most recent trade in ANI Pharmaceuticals Inc was a trade of 4,336 Common Stock done . Disclosure was reported to the exchange on May 22, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
ANI Pharmaceuticals Inc | Antonio R. Pera | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 May 2025 | 4,336 | 35,373 (0%) | 0% | 0 | Common Stock | |
ANI Pharmaceuticals Inc | Antonio R. Pera | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 4,410 | 31,037 (0%) | 0% | 0 | Common Stock | |
ANI Pharmaceuticals Inc | Antonio R. Pera | Director | Sale of securities on an exchange or to another person at price $ 65.20 per share. | 04 Mar 2024 | 7,000 | 26,627 (0%) | 0% | 65.2 | 456,400 | Common Stock |
ANI Pharmaceuticals Inc | Antonio R. Pera | Director | Sale of securities on an exchange or to another person at price $ 60.37 per share. | 14 Aug 2023 | 3,000 | 33,627 (0%) | 0% | 60.4 | 181,110 | Common Stock |
ANI Pharmaceuticals Inc | Antonio R. Pera | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2023 | 6,865 | 36,627 (0%) | 0% | 0 | Common Stock | |
ANI Pharmaceuticals Inc | Antonio R. Pera | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Apr 2022 | 10,049 | 29,762 (0%) | 0% | 0 | Common Stock | |
ANI Pharmaceuticals Inc | Antonio R. Pera | Director | Purchase of securities on an exchange or from another person at price $ 42.26 per share. | 07 Dec 2021 | 3,000 | 19,713 (0%) | 0% | 42.3 | 126,794 | Common Stock |
ANI Pharmaceuticals Inc | Antonio R. Pera | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Mar 2021 | 9,292 | 16,713 (0%) | 0% | 0 | Common Stock | |
ANI Pharmaceuticals Inc | Antonio R. Pera | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Aug 2020 | 16,024 | 16,024 | - | - | Stock Option (right to buy) | |
ANI Pharmaceuticals Inc | Antonio R. Pera | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Aug 2020 | 7,421 | 7,421 (0%) | 0% | 0 | Common Stock |